New Zealand markets close in 5 hours 50 minutes

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.60+0.62 (+6.90%)
At close: 04:00PM EST
9.57 -0.03 (-0.31%)
After hours: 04:24PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
42,226
45,285
0
0
Operating expenses
Research development
72,809
73,271
89,002
70,683
Selling general and administrative
96,734
68,490
40,039
18,603
Total operating expenses
169,543
141,761
129,041
89,286
Operating income or loss
-128,959
-96,476
-129,041
-89,286
Interest expense
3,365
1,778
-
-
Total other income/expenses net
-262
-542
6,594
3,998
Income before tax
-132,521
-97,844
-122,447
-85,288
Income tax expense
1,158
1,410
-
-
Income from continuing operations
-133,679
-99,254
-122,447
-85,288
Net income
-133,679
-99,254
-122,447
-85,288
Net income available to common shareholders
-133,679
-99,254
-122,447
-85,288
Basic EPS
-
-2.62
-3.27
-2.56
Diluted EPS
-
-2.62
-3.27
-2.56
Basic average shares
-
37,878
37,499
33,317
Diluted average shares
-
37,878
37,499
33,317
EBITDA
-
-95,484
-128,685
-89,111